Boston Scientific Delivers 12% Revenue Growth in Q1 2026
BSX|EPS $0.80 vs $0.79 est (+1.3%)|Rev $5.20B|Net Income $1.34B Guidance adjusted $0.82 – $0.84|Stock $59.52 (-2.4%) Solid beat. Boston Scientific Corporation (NYSE:BSX) delivered Q1 2026 adjusted earnings of $0.80 per share, surpassing analysts’ $0.79 forecast by 1.3%, while revenue totaled $5.20B for the quarter. The medical device maker posted revenue growth of 11.6% from $4.66B […]
Boston Scientific Delivers 12% Revenue Growth in Q1 2026 Read More »




